UK Generics Market Set for Superfluous Upsurge

The UK generics market has changed quite drastically during the past few years. If we look at the UK generic market some fifteen years ago, it was largely a national market that comprised of national manufacturers, many of whom were owned by originator companies, who then divested themselves of these small local national businesses. This divestment created an independent national market in the UK until these companies were bought up by growing multinational generic companies. This created today’s structure, where the greatest proportion of generic medicines is made by the global businesses, such as TEVA, Sandoz, Actavis, Mylan, etc. Due to the presence of several generics manufacturers, revenue generated by generics market in the UK is anticipated to grow at a CAGR of over 16% during 2011-2013, says our new research report “UK Generics Market Analysis”.

 

Further, the main reason due to which, the government is so concerned for the development of generics industry is the average cost of brands and generics in the UK. If there was no generic competition and the average cost of all medicines was the average cost of brands, the NHS bill would increase by GBP 8.6 Billion (US$ 13.9 Billion). This is an enormous cost that would double the drugs bill. This fact alone already makes the generic industry absolutely invaluable to the government.

 

Our team of experts has done extensive research on the generics market in the UK and has segmented it on the basis of value of drugs sold, number of prescriptions, and therapeutics. For each segment, detail description and statistics have been included in the report.

 

“UK Generics Market Analysis” provides thorough research and rational analysis along with reliable statistics of the UK generics market. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the UK generics market segments across the country has been covered in the report. The report has thoroughly examined current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years.

For more information visit: http://www.rncos.com/Report/IM313.htm